sevoflurane + isoflurane-Austin Health

sevoflurane + isoflurane-Austin Health refers to a clinical trial context (NCT00126308) conducted by Austin Health comparing the renal safety of two volatile anesthetic agents, sevoflurane and isoflurane, in adult patients with pre-existing renal impairment. Both agents are halogenated ethers used for the induction and maintenance of general anesthesia. They function primarily by enhancing inhibitory neurotransmission through positive allosteric modulation of GABA-A and glycine receptors, while also inhibiting excitatory pathways such as NMDA and nicotinic acetylcholine receptors. The study specifically investigated the impact of low-flow fresh gas administration on post-operative creatinine levels, addressing concerns regarding the potential nephrotoxicity of sevoflurane's degradation product, Compound A, in patients with compromised kidney function.

Brand names

UltaneSevoraneForaneTerrell

Other names

sevofluraneisoflurane